ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage.

Chatterjee Payel; Schweizer Michael T; Lucas Jared M; Coleman Ilsa; Nyquist Michael D; Frank Sander B; Tharakan Robin; Mostaghel Elahe; Luo Jun; Pritchard Colin C; Lam Hung Ming; Corey Eva; Antonarakis Emmanuel S; Denmeade Samuel R; Nelson Peter S
Journal of Clinical Investigation2019-7-16DOI: 10.1172/JCI127613
11阅读
引用收藏
分享

摘要

Prostate cancer (PC) is initially dependent on androgen receptor (AR) signaling for survival and growth. Therapeutics designed to suppress AR activity serve as the primary intervention for advanced disease. However, supraphysiological androgen (SPA) concentrations can produce paradoxical responses leading to PC growth inhibition. We sought to discern the mechanisms by which SPA inhibits PC and to determine if molecular context associates with anti-tumor activity. SPA produced an AR-mediated, dose-dependent induction of DNA double-strand breaks (DSBs), G0/G1 cell cycle arrest and cellular senescence. SPA repressed genes involved in DNA repair and delayed the restoration of damaged DNA which was augmented by PARP1 inhibition. SPA-induced DSBs were accentuated in BRCA2-deficient PCs, and combining SPA with PARP or DNA-PKcs inhibition further repressed growth. Next-generation sequencing was performed on biospecimens from PC patients receiving SPA as part of ongoing Phase II clinical trials. Patients with mutations in genes mediating homology-directed DNA repair were more likely to exhibit clinical responses to SPA. These results provide a mechanistic rationale for directing SPA therapy to PCs with AR amplification or DNA repair deficiency, and for combining SPA therapy with PARP inhibition.

学科与关键词

关键词
EndocrinologyOncologyProstate cancer
相关
加载中…
  • Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer
    Wang, Shan*; Gilbreath, Collin; Kollipara, Rahul K.; Sonavane, Rajni; Huo, Xiaofang; Yenerall, Paul; Das, Amit; Ma, Shihong; Raj, Ganesh, V; Kittler, Ralf*Cancer Letters, 2020, 488: 40-49.
  • Prostate Cancer with Germline DNA Damage Repair Gene Alterations: A Clinical and Pathologic Assessment
    Gopalan, Anuradha; Fine, Samson; Chen, Ying-Bei; Al-Ahmadie, Hikmat; Sarungbam, Judy; Abida, Wassim; Scher, Howard; Tickoo, Satish; Reuter, Victor109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Los Angeles, CA, 2020-02-29 To 2020-03-05.
  • Targeting c-MET to Enhance the Efficacy of Olaparib in Prostate Cancer
    Wang, Zhenwei; Dai, Zhihong; Wang, Bingwei; Gao, Yuren; Gao, Xiang; Wang, Liang; Zhou, Sihai; Yang, Liqin; Qiu, Xiaofu; Liu, Zhiyu*OncoTargets and Therapy, 2021, 14: 4383-4389.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Clinical Investigation
发表日期
2019-07-16
卷期
第 130 卷
DOI
10.1172/JCI127613
语言
ENGLISH
期刊收录
NATURE-INDEX
成果收录
PUBMED

作者

  • C

    Chatterjee Payel (第一作者)

  • S

    Schweizer Michael T

查看全部 15 位作者收起作者
  • L

    Lucas Jared M

  • C

    Coleman Ilsa

  • N

    Nyquist Michael D

  • F

    Frank Sander B

  • T

    Tharakan Robin

  • M

    Mostaghel Elahe

  • L

    Luo Jun

  • P

    Pritchard Colin C

  • L

    Lam Hung Ming

  • C

    Corey Eva

  • A

    Antonarakis Emmanuel S

  • D

    Denmeade Samuel R

  • N

    Nelson Peter S

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417